Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 81.45

-1.6%

Dec 29 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (16)	9/3/2002 12:07:57 PM
From: Jibacoa	Read Replies (1) of 3722

DGEN Is up 16.67% on low volume (only 2,500 shares or about 1/23 of its daily average) It is somewhat of an accomplishment in view of the current general market condition (the DOW is down 281 with not a single one of the DOW companies out of the red column today) Of course DGEN has been trading not only below its reported book, but also below its cash/share and the fact that the insiders hold more than 80% of the shares and institutions close to 330% of the float is also to its favor. (The float is only around 7 million.) In the 2nd Q which ended on June 30, they reported more than a 100% increase on "research and development" (21.2M vs.10.4M) compared with the 2nQ last year. The list of "partnership agreements" and "collaborators" include some companies like Eli Lilly,Hyseq, Pfizer, GlaxoSmithKline and Merck. siliconinvestor.com The R/R appears to be favorable at present levels, but I would like to see it closing above $2 and plan of adding on a close above $3. (Hoping of course, that by that time we will have a better environment.) siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next